Sunzen Biotech Bhd (0148) - Total Liabilities

Latest as of March 2024: RM18.73 Million MYR ≈ $4.70 Million USD

Based on the latest financial reports, Sunzen Biotech Bhd (0148) has total liabilities worth RM18.73 Million MYR (≈ $4.70 Million USD) as of March 2024. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 0148 asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Sunzen Biotech Bhd - Total Liabilities Trend (2016–2023)

This chart illustrates how Sunzen Biotech Bhd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see 0148 total assets.

Sunzen Biotech Bhd Competitors by Total Liabilities

The table below lists competitors of Sunzen Biotech Bhd ranked by their total liabilities.

Company	Country	Total Liabilities
Xander International TWO:6118	Taiwan	NT$2.52 Billion
Metal Sky Star Acquisition Corporation Ordinary shares NASDAQ:MSSA	USA	$8.21 Million
AViTA Corporation TWO:4735	Taiwan	NT$673.53 Million
Hastings Technology Metals Ltd AU:HAS	Australia	AU$137.26 Million
S P V I Public Company Limited BK:SPVI	Thailand	฿730.69 Million
Batm Advanced Communications Ltd TA:BVC	Israel	ILA48.80 Million
YNH Property Bhd KLSE:3158	Malaysia	RM1.41 Billion
Sportsmans NASDAQ:SPWH	USA	$704.35 Million

Liability Composition Analysis (2016–2023)

This chart breaks down Sunzen Biotech Bhd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See net asset quality index of Sunzen Biotech Bhd to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	6.71	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.14	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.12	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Sunzen Biotech Bhd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Sunzen Biotech Bhd (2016–2023)

The table below shows the annual total liabilities of Sunzen Biotech Bhd from 2016 to 2023.

Year	Total Liabilities	Change
2023-12-31	RM20.51 Million ≈ $5.15 Million	-29.46%
2022-12-31	RM29.08 Million ≈ $7.30 Million	-5.01%
2021-12-31	RM30.61 Million ≈ $7.69 Million	-14.34%
2020-12-31	RM35.73 Million ≈ $8.97 Million	-3.32%
2019-12-31	RM36.96 Million ≈ $9.28 Million	-9.05%
2018-12-31	RM40.63 Million ≈ $10.20 Million	+106.30%
2017-12-31	RM19.70 Million ≈ $4.95 Million	+119.33%
2016-12-31	RM8.98 Million ≈ $2.25 Million	--

About Sunzen Biotech Bhd

KLSE:0148 Malaysia Packaged Foods

Market Cap

$43.17 Million

RM171.96 Million MYR

Market Cap Rank

#22547 Global

#510 in Malaysia

Share Price

RM0.22

Change (1 day)

+0.00%

52-Week Range

RM0.22 - RM0.30

All Time High

RM0.44